Cochrane Abstracts
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antimetabolites as an Adjunct to Dacryocystorhinostomy for Nasolacrimal Duct Obstruction." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Antimetabolites_as_an_adjunct_to_dacryocystorhinostomy_for_nasolacrimal_duct_obstruction.
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Antimetabolites_as_an_adjunct_to_dacryocystorhinostomy_for_nasolacrimal_duct_obstruction. Accessed February 14, 2026.
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Antimetabolites_as_an_adjunct_to_dacryocystorhinostomy_for_nasolacrimal_duct_obstruction
Antimetabolites as an Adjunct to Dacryocystorhinostomy for Nasolacrimal Duct Obstruction [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Antimetabolites_as_an_adjunct_to_dacryocystorhinostomy_for_nasolacrimal_duct_obstruction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
ID - 432319
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Antimetabolites_as_an_adjunct_to_dacryocystorhinostomy_for_nasolacrimal_duct_obstruction
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
